Antibiotic therapy in reconstructive surgery of deep sternal wound infections.

Clinical hemorheology and microcirculation 2024 Vol.86(1-2) p. 183-194

Unbehaun P, Prantl L, Langer S, Spindler N

관련 도메인

Abstract

[BACKGROUND] The choice of antibiotics and length of administration in the treatment of deep sternal wound infections (DSWI) is unclear. The reason for this is the lack of studies and local differences in resistance. An increase in resistance can be observed in gram-positive cocci, which are the most frequently detected in deep sternal infections. The duration of administration is often 2- 6 weeks or longer, although the benefit of prolonged antibiotic administration has not been confirmed by studies. We evaluated the antibiotic treatment during surgical treatment, consisting of surgical wound debridement and plastic chest reconstruction.

[METHODS] Retrospective analysis of patients (n = 260) who underwent reconstructive surgery in the Department of Plastic Surgery at Leipzig University Hospital from 01.05.2012 - 31.12.2020. The duration of intake, results of microbiological swabs and resistance were investigated.

[RESULTS] At the time of discharge, closed wound conditions were noted in 177 of 260 cases (68.1%). The largest proportion of patients (n = 238) was treated with a latissimus dorsi flap (91.5%).Antibiotic treatment was conducted in 206 of 260 cases (79.2%). The mean duration of antibiotic administration was 21.4 days (±17.6). Prolonged treatment over 14 days did not alter outcome (p = 0.226), in contrast, the number of multidrug resistances (p < 0.001). There was no prove of resistance against linezolid which is effective against the most common found infectious agents Staphylococcus epidermidis (n = 93; 24.0 %) & Staphylococcus aureus (n = 47; 12.1 %).

[CONCLUSION] There is no evidence of benefit from antibiotic therapy over 14 days, whereas multidrug resistance increases with prolonged antibiotic use. In the absence of infectious agents or clinical signs of inflammation, surgical treatment without additional antibiotic treatment is effective.Linezolid is a suitable antibiotic in the treatment of gram-positive infections which are the most frequent in DSWI.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 latissimus dorsi flap 피판재건술 dict 1
합병증 wound scispacy 1
약물 cocci C0314746
Cocci (bacteria)
scispacy 1
약물 linezolid C0663241
linezolid
scispacy 1
약물 epidermidis scispacy 1
약물 [BACKGROUND] scispacy 1
질환 sternal infections scispacy 1
질환 inflammation C0021368
Inflammation
scispacy 1
질환 infections C0851162
Infections of musculoskeletal system
scispacy 1
질환 gram-positive cocci scispacy 1
질환 DSWI → deep sternal wound infections scispacy 1
기타 patients scispacy 1

MeSH Terms

Humans; Surgery, Plastic; Linezolid; Retrospective Studies; Surgical Wound Infection; Treatment Outcome; Anti-Bacterial Agents

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문